The P/F Program aims to support the development of new digestive diseases-related research initiatives. Limited funding will be provided for: 1) testing of novel hypotheses which may have impact on digestive diseases research, and 2) obtaining preliminary data to support future applications for extramural funding. Funds will be provided for up to four 1-2 year projects (with second year funding subject to competitive renewal), and three categories of investigators will be considered: 1) unfunded young investigators (or investigators holding career development awards) seeking to obtain independent grant support, 2) established investigators in other scientific fields who wish to enter the area of GI research, and 3) investigators currently involved in digestive diseases-related research who wish to pursue a new research direction not supported by their current grants. The budget is limited to $22,000 per year, per project, with a maximum total of $88,000. Applications will be solicited from every faculty member on an annual basis (in April, with a reminder sent via e-mail one month later as a means to increase the applicant pool), and additional announcements will be made in the DDRCC newsletter, the DDRCC Home Page, the Washington University Campus Newspaper, and the publication of the Washington University Academic Women's Network (AWNings). Promising postdoctoral fellows, instructors involved in GI research, and established investigators in other fields whose area of expertise could be applied to GI-related research, will be approached directly by the director of the program. Initial review of submitted projects will be carried out by members of the Executive Committee and the Internal Scientific Advisory Board. Outside reviewers will be sought if required expertise is missing. Following revision, selected projects will be evaluated and prioritized by an External Scientific Advisory Board consisting of six senior investigators from outside Washington University. The projects will be evaluated with respect to likelihood of developing into GI-related projects that will successfully compete for extramural (e.g., NIDDK) funding. An appropriate mechanism has also been developed for review of ongoing projects and allocation of second year funding. In preparation for this application, eight P/F projects were received and evaluated by at least six internal reviewers. The projects were ranked according to their averaged scores, and the top four (by Drs. Dieckgraefe, Simon, Wilson, and Heuckeroth) were included with the application. Also included were the critiques provided by the internal reviewers. The top two projects (Drs. Dieckgraefe and Simon) have been funded with seed money provided by the Dean of the Washington University School of Medicine (Dr. William Peck). Should this application for a DDRCC be funded, Drs. Dieckgraefe and Simon will be funded for a second year (subject to a satisfactory progress report) and Drs. Wilson and Heuckeroth will be funded for the first year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK052574-01A1
Application #
6346600
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (J2))
Project Start
2000-03-01
Project End
2004-11-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
$180,000
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Wardill, Hannah R; Van Sebille, Ysabella Z A; Ciorba, Matthew A et al. (2018) Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis. Curr Opin Support Palliat Care 12:187-197
Osaki, Luciana H; Bockerstett, Kevin A; Wong, Chun Fung et al. (2018) Interferon-? directly induces gastric epithelial cell death and is required for progression to metaplasia. J Pathol :
Chandrasekaran, Sukantha; Burnham, Carey-Ann D; Warner, Barbara B et al. (2018) Carriage of Cronobacter sakazakii in the Very Preterm Infant Gut. Clin Infect Dis 67:269-274
Tarr, Gillian A M; Oltean, Hanna N; Phipps, Amanda I et al. (2018) Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity. Int J Med Microbiol 308:1121-1127
Wang, Songyan; Oestricker, Lauren Z; Wallendorf, Michael J et al. (2018) Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. PLoS One 13:e0192441
Jiang, Hongmei; Xu, Mai; Li, Lin et al. (2018) Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Mol Cancer Ther 17:2144-2155
Chondronikola, Maria; Magkos, Faidon; Yoshino, Jun et al. (2018) Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial. Obesity (Silver Spring) 26:683-688
McKee, Ryan S; Tarr, Phillip I; Dietzen, Dennis J et al. (2018) Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea. J Pediatric Infect Dis Soc 7:e116-e122
Nywening, Timothy M; Belt, Brian A; Cullinan, Darren R et al. (2018) Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut 67:1112-1123
Luo, Jialie; Qian, Aihua; Oetjen, Landon K et al. (2018) TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells. Immunity 49:107-119.e4

Showing the most recent 10 out of 899 publications